The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease-A report from Central and Eastern Europe.
The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease-A report from Central and Eastern Europe.
复制标题
轻/无症状和中/重度新冠肺炎病程的艾滋病毒阳性患者的特征-来自中欧和东欧的报告。
DOI:
10.1016/j.ijid.2020.12.026
复制
发表时间:
2021-03
期刊:
影响因子:
--
通讯作者:
Matulionyte R
中科院分区:
文献类型:
--
作者:
Kowalska JD;Kase K;Vassilenko A;Harxhi A;Lakatos B;Lukić GD;Verhaz A;Yancheva N;Dumitrescu F;Jilich D;Machala L;Skrzat-Klapaczyńska A;Matulionyte R
There is currently no evidence suggesting that COVID-19 takes a different course in HIV-positive patients on antiretroviral treatment compared to the general population. However, little is known about the relation between specific HIV-related factors and the severity of the COVID-19 disease. We performed a retrospective analysis of cases collected through an on-line survey distributed by the Euroguidelines in Central and Eastern Europe Network Group. In statistical analyses characteristics of HIV-positive patients, asymptomatic/moderate and moderate/severe course were compared. In total 34 HIV-positive patients diagnosed with COVID-19 were reported by 12 countries (Estonia, Czech Republic, Lithuania, Albania, Belarus, Romania, Serbia, Bosnia and Herzegovina, Poland, Russia, Hungary, Bulgaria). Asymptomatic courses of COVID-19 were reported in four (12%) cases, 11 (32%) patients presented with mild disease not requiring hospitalization, moderate disease with respiratory and/or systemic symptoms was observed in 14 (41%) cases, and severe disease with respiratory failure was found in five (15%) patients. The HIV-related characteristics of patients with an asymptomatic/mild course of COVID-19 were comparable to those with a moderate/severe course of COVID-19, except for the use of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in cART regimen (0.0% vs. 31.6% respectively, p = 0.0239). In our analyses HIV viral suppression and immunological status were not associated with the course of COVID-19 disease. On the contrary the cART regimen could contribute to severity of SARS-CoV-2 infection. Large and prospective studies are necessary to further investigate this relationship.
登录
查看更多内容
影响因子:
3
作者:
Waters, L.;Rockstroh, J. K.
通讯作者:
Rockstroh, J. K.
影响因子:
11.8
作者:
Dandachi, Dima;Geiger, Grant;Chow, Jeremy
通讯作者:
Chow, Jeremy
影响因子:
11.8
作者:
Guaraldi, Giovanni;Orlando, Gabriella;Palella, Frank
通讯作者:
Palella, Frank
影响因子:
39.2
作者:
del Amo, Julia;Polo, Rosa;Hernan, Miguel A.
通讯作者:
Hernan, Miguel A.
影响因子:
158.5
作者:
Cao, B.;Wang, Y.;Wang, C.
通讯作者:
Wang, C.